EGFR and glioblastoma: Therefore we examined whether oxelaidin is effective in inhibiting chemoresistance of glioblastoma cell lines, including constitutively active EGFR vIII-expressing U87MG (U87MG-vIII), temozolomide-resistant U87MG (U87MG-TMZR) and high MGMT-expressing T98G.